Last reviewed · How we verify
succinimide
succinimide is a drug. It is currently in unknown development for Primary hyperoxaluria.
Succinimide is a small molecule organic compound with the formula (CH2)2(CO)2NH, classified as a cyclic imide. It is used in various organic syntheses and industrial processes, such as silver plating.
At a glance
| Generic name | succinimide |
|---|---|
| Target | Protein cereblon, Cereblon isoform 4 |
| Therapeutic area | Other |
| Phase | unknown |
Approved indications
- Primary hyperoxaluria
Common side effects
Key clinical trials
- A Randomised Double-blind Placebo-controlled Trial of the Safety and Efficacy of Ethosuximide 250mg Capsules for the Management of Chemotherapy Induced Painful Peripheral Neuropathy (Phase 2)
- Evaluation of the Efficacy and Tolerance of Ethosuximide in the Treatment of Abdominal Pain Associated With Irritable Bowel Syndrome (Phase 2)
- An Open Label, Single-dose, Dose-increasing Study to Assess the Safety, Tolerability, PK and Preliminary PD of PEGylated Recombinant Candida Urate Oxidase (SSS11) for Injection in Chinese Healthy Adul (Phase 1)
- Pharmacologic and Genetic Evaluation of a C. Elegans Model for Migraine (Phase 1)
- Evaluation of the Efficacy and Tolerance of Low Doses of Ethosuximide in the Treatment of Peripheral Neuropathic Pain (Phase 2)
- A Randomized, Parallel-group，Placebo-controlled, Double-blind Clinical Trial to Evaluate the Efficacy and Safety of Ethosuximide in Chinese Patients With Treatment-Resistant Depression. (EARLY/Phase 1)
- A Single Centre. Parallel-Group, Double-Blinded, Randomized, Placebo-Controlled Pilot Clinical Trial on Ethosuximide for the Treatment of Complex Regional Pain Syndrome (CRPS) (Phase 2)
- Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study (Phase 3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- succinimide CI brief — competitive landscape report
- succinimide updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about succinimide
What is succinimide?
succinimide is a pharmaceutical drug, indicated for Primary hyperoxaluria.
What is succinimide used for?
succinimide is indicated for Primary hyperoxaluria.
What development phase is succinimide in?
succinimide is in unknown.
What does succinimide target?
succinimide targets Protein cereblon, Cereblon isoform 4.
Related
- Target: All drugs targeting Protein cereblon, Cereblon isoform 4
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Other
- Indication: Drugs for Primary hyperoxaluria
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing